Allogene Therapeutics, Inc.ALLONASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank63
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-190.89M
↑ 12% vs avg
Percentile
P63
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-216.06M
Historical baseline
PeriodValueYoY Change
TTM$-190.89M+25.9%
2024$-257.59M+21.3%
2023$-327.26M+3.9%
2022$-340.41M-87.0%
2021$-182.05M+27.2%
2020$-250.22M-35.6%
2019$-184.59M+12.7%
2018$-211.50M-10575150.0%
2017$-2000.00-